Source: Annual Congress 2007 - Pulmonary hypertension: diagnosis and treatment
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Miranda-Malpica, T. Pulido-Zamudio, M. Porres-Aguilar, N. Espinola, E. Vallejo, L. Jimenez, A. Meave, E. Bautista, E. Santos, M. L. Martinez-Guerra, C. J. Gonzalez-Quesada, J. Sandoval (Mexico City, Mexico). Dipyridamole as adjuvant therapy in patients with pulmonary arterial hypertension. A pilot study. Eur Respir J 2007; 30: Suppl. 51, 1806

Member's Comments

No comment yet.

Related content which might interest you: Effect of long-term oxygen therapy on exercise capacity and quality of life in exercise-desaturating patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension: a randomized-sham-controlled cross-over trial Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017 Pulmonary haemodynamics during exercise in patients with pulmonary arterial hypertension Source: Annual Congress 2005 - Exercise testing in pulmonary arterial hypertension Year: 2005 Optimal management of severe pulmonary arterial hypertension Source: Eur Respir Rev 2011; 20: 254-261 Year: 2011 Pathophysiology of exercise limitation in patients with pulmonary arterial hypertension Source: Annual Congress 2005 - Exercise testing in pulmonary arterial hypertension Year: 2005 Hemodynamic effects of sildenafil in pulmonary arterial hypertension (PAH) patients Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension Year: 2005 Everolimus improves exercise capacity and pulmonary vascular resistance in patients with advanced pulmonary hypertension – A pilot study Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 A screening protocol for pulmonary hypertension in systemic sclerosis identifies patients with pulmonary hypertension on exercise Source: Eur Respir J 2004; 24: Suppl. 48, 277s Year: 2004 Update on current treatment options of pulmonary hypertension Source: Annual Congress 2006 - Pulmonary hypertension at the crossroads of science and clinical medicine Year: 2006 Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension Source: Eur Respir J 2012; 40: 1410-1419 Year: 2012 The effects of beta-blocker therapy on heart rate, symptoms and exercise in pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment Year: 2013 Exercise stress echocardiography for the study of the pulmonary circulation Source: Eur Respir J 2010; 35: 1273-1278 Year: 2010 Screening for pulmonary vascular disease (PVD) in patients with portal hypertension by investigating pulmonary hemodynamics during exercise Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension Year: 2017 Sildenafil effects on 1-year survival of patients with idiopathic pulmonary arterial hypertension (IPAH) Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension Year: 2005 Challenges in the diagnosis and treatment of pulmonary arterial hypertension Source: Eur Respir Rev 2012 21: 313-320 Year: 2012 Bosentan improves exercise tolerance and Tei index in patients with pulmonary hypertension and prostanoid therapy Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension Year: 2005 Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children Source: Eur Respir J 2011; 37: 70-77 Year: 2011 Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2) Source: Eur Respir J 2015; 45: 1303-1313 Year: 2015 Chronic thromboembolic pulmonary hypertension: role of medical therapy Source: Eur Respir J 2013; 41: 985-990 Year: 2013 The study of risk in pulmonary arterial hypertension Source: Eur Respir Rev 2012 21:234-238 Year: 2012